Royal College of Physicians (RCP) -
This report, from a RCP and British Pharmacological Society joint working party, explains how a type of testing, known as pharmacogenomic testing, should be deployed across the NHS to ensure all patients have an equal chance of being prescribed a medicine at a dose that is likely to be safe and effective for them, with minimal side effects. There can be enormous variation from person to person in whether a medicine works, whether it causes serious side effects and what dose is needed. The report states that testing patients for genetic variations that affect how their body will respond to common medicines must be integrated fully, fairly and swiftly into the NHS.